SCHEMBL8251925

SCHEMBL8251925

CC(C)OC(=O)NCC(=O)N1CCC[C@H]1C=O

nearest known ligand 0.44

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 13/20 0.44
▸ PREP P48147 8/20 0.44
▸ FAP Q12884 6/20 0.44
▸ DPP8 Q6V1X1 2/20 0.34
▸ DPP9 Q86TI2 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8253605 0.90 DPP4 (0.42) DPP4PREPFAP
SCHEMBL8253564 0.86 DPP4 (0.44) DPP4PREPFAPDPP8DPP9
SCHEMBL8254365 0.84 RAB9A (0.45) DPP4PREPFAP
SCHEMBL8354731 0.82 DPP4 (0.42) DPP4PREPFAPDPP8DPP9
SCHEMBL8247017 0.81 MEN1 (0.49) DPP4PREPFAPDPP8DPP9
SCHEMBL8249414 0.80 PREP (0.43) DPP4PREPFAP
SCHEMBL2557245 0.80 DPP4 (0.61) DPP4PREPFAPDPP8DPP9
SCHEMBL2557248 0.80 DPP4 (0.61) DPP4PREPFAPDPP8DPP9
SCHEMBL9769216 0.78 RAB9A (0.41) —
SCHEMBL12018904 0.78 RAB9A (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006130607-A2 CONTROLLED-RELEASE FORMULATION USEFUL FOR TREATING DISORDERS ASSOCIATED WITH HEPATITIS C VIRUS SCHERING CORPORATION (US) 2006-12-07 — — WO disclosed
WO-2006113942-A2 METHOD OF INHIBITING CATHEPSIN ACTIVITY SCHERING CORPORATION (US) 2006-10-26 — — WO disclosed
Send feedback